MarsBio

NAPIGEN is a biotechnology company focused on advancing genome engineering across a range of organisms, including plants, microbes, and animals. The company's innovative technology specifically targets mitochondria and chloroplasts, which are organelles that contain their own DNA and play crucial roles in cellular energy production. By harnessing the potential of these organelles, NAPIGEN aims to develop solutions that enhance the growth and efficiency of various biological systems, ultimately contributing to a more convenient and sustainable society.

Founded in 2019, Karma Biotechnologies is a Los Angeles-based company dedicated to developing therapies for autoimmune diseases, allergies, and food sensitivities. It specializes in antigen-specific immunotherapies using lipid nanoparticle engineering.

Spira develops algae-based ingredients and natural pigments to replace petrochemicals and animal-derived compounds. By engineering microalgae, including spirulina, it produces food-safe dyes and industrial ingredients used across food, cosmetics, and textiles. Spira focuses on sustainable, regenerative alternatives to petroleum-based products to reduce environmental impact while supporting human and planetary health.